PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
CPRX vs. TPL
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

CPRX vs. TPL

Last updated Apr 1, 2026

Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL).

Performance

CPRX vs. TPL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CPRX vs. TPL - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
CPRX
Catalyst Pharmaceuticals, Inc.		6.08%11.84%24.15%-9.62%174.74%102.69%-10.93%95.31%-50.90%272.38%
TPL
Texas Pacific Land Corporation		65.41%-21.61%115.31%-32.40%91.29%73.25%-4.69%44.58%21.96%51.18%

Fundamentals

Market Cap

CPRX:

$3.15B

TPL:

$32.76B

EPS

CPRX:

$1.68

TPL:

$6.97

PE Ratio

CPRX:

14.71

TPL:

68.06

PEG Ratio

CPRX:

0.26

TPL:

3.60

PS Ratio

CPRX:

5.35

TPL:

41.04

PB Ratio

CPRX:

3.30

TPL:

22.45

Total Revenue (TTM)

CPRX:

$588.99M

TPL:

$798.19M

Gross Profit (TTM)

CPRX:

$726.82M

TPL:

$798.19M

EBITDA (TTM)

CPRX:

$257.78M

TPL:

$655.46M

Returns By Period

In the year-to-date period, CPRX achieves a 6.08% return, which is significantly lower than TPL's 65.41% return. Over the past 10 years, CPRX has underperformed TPL with an annualized return of 35.35%, while TPL has yielded a comparatively higher 41.62% annualized return.

CPRX

1D
4.12%
1M
7.28%
YTD
6.08%
6M
25.69%
1Y
2.10%
3Y*
14.30%
5Y*
40.58%
10Y*
35.35%

TPL

1D
1.54%
1M
-9.38%
YTD
65.41%
6M
52.94%
1Y
8.11%
3Y*
37.44%
5Y*
23.18%
10Y*
41.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Catalyst Pharmaceuticals, Inc.

Texas Pacific Land Corporation

Often compared with CPRX:
CPRX vs. CLCPRX vs. BMRNCPRX vs. XPELCPRX vs. AADICPRX vs. ENSGCPRX vs. MOHCPRX vs. FLGT
Often compared with TPL:
TPL vs. PBTTPL vs. LANDOTPL vs. DARTPL vs. UFPTTPL vs. LBTPL vs. TSLATPL vs. VOO

Return for Risk

CPRX vs. TPL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
CPRX
CPRX Risk / Return Rank: 4141
Overall Rank
CPRX Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
CPRX Sortino Ratio Rank: 3838
Sortino Ratio Rank
CPRX Omega Ratio Rank: 3737
Omega Ratio Rank
CPRX Calmar Ratio Rank: 4242
Calmar Ratio Rank
CPRX Martin Ratio Rank: 4141
Martin Ratio Rank
TPL
TPL Risk / Return Rank: 4646
Overall Rank
TPL Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
TPL Sortino Ratio Rank: 4545
Sortino Ratio Rank
TPL Omega Ratio Rank: 4444
Omega Ratio Rank
TPL Calmar Ratio Rank: 4848
Calmar Ratio Rank
TPL Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CPRX vs. TPL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

CPRXTPLDifference

Sharpe ratio

Return per unit of total volatility

0.06

0.17

-0.11

Sortino ratio

Return per unit of downside risk

0.32

0.58

-0.26

Omega ratio

Gain probability vs. loss probability

1.04

1.08

-0.04

Calmar ratio

Return relative to maximum drawdown

0.01

0.23

-0.22

Martin ratio

Return relative to average drawdown

0.02

0.35

-0.33

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CPRX vs. TPL - Sharpe Ratio Comparison

The current CPRX Sharpe Ratio is 0.06, which is lower than the TPL Sharpe Ratio of 0.17. The chart below compares the historical Sharpe Ratios of CPRX and TPL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

CPRXTPLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.06

0.17

-0.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.85

0.51

+0.34

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.56

0.90

-0.33

Sharpe Ratio (All Time)

Calculated using the full available price history

0.08

0.58

-0.50

Correlation

The correlation between CPRX and TPL is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CPRX vs. TPL - Dividend Comparison

CPRX has not paid dividends to shareholders, while TPL's dividend yield for the trailing twelve months is around 0.46%.

TTM20252024202320222021202020192018201720162015
CPRX
Catalyst Pharmaceuticals, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TPL
Texas Pacific Land Corporation		0.46%0.74%1.37%0.83%1.37%0.88%2.20%0.22%0.55%0.30%0.10%0.22%

Drawdowns

CPRX vs. TPL - Drawdown Comparison

The maximum CPRX drawdown since its inception was -94.25%, which is greater than TPL's maximum drawdown of -73.05%. Use the drawdown chart below to compare losses from any high point for CPRX and TPL.

Loading graphics...

Drawdown Indicators

CPRXTPLDifference

Max Drawdown

Largest peak-to-trough decline

-94.25%

-73.05%

-21.20%

Max Drawdown (1Y)

Largest decline over 1 year

-27.29%

-42.34%

+15.05%

Max Drawdown (5Y)

Largest decline over 5 years

-45.37%

-52.50%

+7.13%

Max Drawdown (10Y)

Largest decline over 10 years

-64.87%

-65.46%

+0.59%

Current Drawdown

Current decline from peak

-5.89%

-17.02%

+11.13%

Average Drawdown

Average peak-to-trough decline

-52.51%

-27.26%

-25.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.10%

27.98%

-12.88%

Volatility

CPRX vs. TPL - Volatility Comparison

The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 10.39%, while Texas Pacific Land Corporation (TPL) has a volatility of 11.83%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than TPL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

CPRXTPLDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.39%

11.83%

-1.44%

Volatility (6M)

Calculated over the trailing 6-month period

23.71%

32.57%

-8.86%

Volatility (1Y)

Calculated over the trailing 1-year period

34.96%

48.59%

-13.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.24%

45.74%

+2.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

62.81%

46.53%

+16.28%

Financials

CPRX vs. TPL - Financials Comparison

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Texas Pacific Land Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

50.00M100.00M150.00M200.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
152.61M
211.58M
(CPRX) Total Revenue
(TPL) Total Revenue
Values in USD except per share items